Palatin Technologies
PTN
#10101
Rank
A$35.96 M
Marketcap
A$21.12
Share price
-1.74%
Change (1 day)
1,326.24%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$7.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$8.84 Million. In 2024 the company made an earning of -A$38.69 Million, an increase over its 2023 earnings that were of -A$46.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.94 Million-79.5%
2024 -A$38.69 Million-16.9%
2023 -A$46.55 Million5.99%
2022 -A$43.93 Million-13.7%
2021 -A$50.9 Million33.25%
2020 -A$38.2 Million-172.11%
2019 A$52.96 M2352.33%
2018 A$2.15 M-94.13%
2017 A$36.8 M-154.92%
2016 -A$67.01 Million3.67%
2015 -A$64.64 Million878%
2014 -A$6.61 Million-72.64%
2013 -A$24.16 Million-33.11%
2012 -A$36.12 Million77.71%
2011 -A$20.33 Million
2003 -A$34.41 Million29.93%
2002 -A$26.49 Million36.18%
2001 -A$19.45 Million
1999 -A$16.15 Million6.04%
1998 -A$15.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$18.79 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$0.83 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$17.24 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$95.91 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$72.58 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$42.35 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$79.77 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA